PUBLICAÇÕES científicas

Expression of S6K1 in human visceral adipose tissue is upregulated in obesity and related to insulin resistance and inflammation

Catalán V [ES] (1), Gómez-Ambrosi J [ES], Rodríguez A, Ramírez B, Andrada P, Rotellar F, Valentí V, Moncada R, Martí P [ES], Silva C [ES], Salvador J, Frühbeck G
(1) Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain. 

Revisão:Acta Diabetológica

Data: 1/Abr/2015

Endocrinologia e Nutrição [ES] Cirurgia Geral e Digestiva Área de Obesidade Anestesia e Cuidados Intensivos [ES]

RESUMO

The ribosomal protein S6 kinase 1 (S6K1) is a component of the insulin signalling pathway that has been proposed as a key molecular factor in insulin resistance development under conditions of nutrient overload.

The aim was to evaluate the involvement of S6K1 in obesity as well as to explore their association with visceral adipose tissue (VAT) inflammation. Samples obtained from 40 subjects were used. Gene expression levels of RPS6KB1 and key inflammatory markers were analysed in VAT.

The effect of insulin on transcript levels of RPS6KB1 in human differentiated adipocytes was also explored. RPS6KB1 mRNA levels in VAT were increased (P < 0.05) in obese patients. Insulin treatment significantly enhanced (P < 0.01) gene expression levels of RPS6KB1 and a positive association (P < 0.05) of RPS6KB1 expression with different markers of insulin resistance was observed.

Moreover, RPS6KB1 gene expression levels were positively correlated with VAT gene expression levels of the inflammatory markers CCL2, CD68, MMP2, MMP9, VEGFA and CHI3L1 as well as with mRNA levels of MTOR and MAPK8, representative players involved in signalling pathways related to S6K1.

The increased levels of S6K1 in obesity and its positive association with insulin resistance and inflammation suggest a role for this protein in the changes that take place in VAT in obesity establishing a link between inflammation and a higher risk for the development of metabolic diseases.

CITAÇÃO DO ARTIGO  Acta Diabetol. 2015 Apr;52(2):257-66. doi: 10.1007/s00592-014-0632-9. Epub 2014 Aug 14

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra